LTA II Kit Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with LTA II Kit
S
- Scandonest L (levonordefrin / mepivacaine)
- Scandonest Plain (mepivacaine)
- Se-Donna PB HYOS (atropine / hyoscyamine / phenobarbital / scopolamine)
- Sensorcaine (bupivacaine)
- Sensorcaine with Epinephrine (bupivacaine / epinephrine)
- Sensorcaine-MPF (bupivacaine)
- Sensorcaine-MPF Spinal (bupivacaine)
- Sensorcaine-MPF with Epinephrine (bupivacaine / epinephrine)
- Septocaine (articaine / epinephrine)
- Septra (sulfamethoxazole / trimethoprim)
- Septra DS (sulfamethoxazole / trimethoprim)
- Septra IV (sulfamethoxazole / trimethoprim)
- Servira (atropine / hyoscyamine / phenobarbital / scopolamine)
- Sezaby (phenobarbital)
- Siklos (hydroxyurea)
- Silvadene (silver sulfadiazine topical)
- Silvadene Cream 1% (silver sulfadiazine topical)
- silver nitrate topical
- silver sulfadiazine topical
- SkyaDerm-LP (lidocaine / prilocaine topical)
- SMZ-TMP DS (sulfamethoxazole / trimethoprim)
- sodium nitrite
- sodium nitrite/sodium thiosulfate
- Solfoton (phenobarbital)
- Sorbitrate (isosorbide dinitrate)
- Spasmolin (atropine / hyoscyamine / phenobarbital / scopolamine)
- Spasquid (atropine / hyoscyamine / phenobarbital / scopolamine)
- Spastrin (belladonna / ergotamine / phenobarbital)
- SSD (silver sulfadiazine topical)
- SSD AF (silver sulfadiazine topical)
- sulfadiazine
- sulfamethizole
- sulfamethoxazole
- sulfamethoxazole / trimethoprim
- sulfasalazine
- Sulfatrim (sulfamethoxazole / trimethoprim)
- Sulfatrim Pediatric (sulfamethoxazole / trimethoprim)
- Sulfazine (sulfasalazine)
- Sulfimycin (erythromycin / sulfisoxazole)
- sulfisoxazole
More about LTA II Kit (lidocaine topical)
- LTA II Kit consumer information
- Check interactions
- Compare alternatives
- Latest FDA alerts (8)
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical anesthetics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.